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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYAdvances in stem cellmanufacturingmethods havemade it possible to produce stem cell-derived cardiacmyocytes at industrial scales for
in vitro muscle physiology research purposes. Although FDA-mandated quality assurance metrics address safety issues in the manufac-
ture of stem cell-based products, no standardized guidelines currently exist for the evaluation of stem cell-derivedmyocyte functionality.
As a result, it is unclear whether the various stem cell-derivedmyocyte cell lines on themarket perform similarly, or whether any of them
accurately recapitulate the characteristics of native cardiac myocytes. We propose a multiparametric quality assessment rubric in which
genetic, structural, electrophysiological, and contractile measurements are coupled with comparison against values for these measure-
ments that are representative of the ventricular myocyte phenotype. We demonstrated this procedure using commercially available,
mass-producedmurine embryonic stem cell- and induced pluripotent stem cell-derivedmyocytes compared with a neonatal mouse ven-
tricular myocyte target phenotype in coupled in vitro assays.INTRODUCTION
In response towidespread efforts to commercialize differen-
tiated stem cells (Brower, 1999), the U.S. Food and Drug
Administration (FDA) established a set of regulations and
guidelines for manufacturing and quality-control evalua-
tions of human cellular and tissue-based products derived
from stem cells (FDA, 2011). The recommendations out-
lined for evaluating differentiated stem cell phenotypes
were developed specifically to address patient safety
concerns such as tumorigenicity and immunologic incom-
patibility, due to the initial focus of the industry on regen-
erative-medicine applications (Fink, 2009). Concerns about
patient safety may have slowed the commercialization of
regenerative therapies (Fox, 2011), but the use of industrial
stem cell-based products for in vitro research, particularly
pharmaceutical screening applications (Placzek et al.,
2009; Rubin, 2008; Thomson, 2007; Wobus and Lo¨ser,
2011), is a promising goal that can potentially be reached
in the near term. Due to the mandate to test all drug com-
pounds for potential adverse effects on the heart, in vitro
cardiac toxicity screening is a particularly important appli-
cation that has prompted the development of commercial
stem cell-derived cardiac myocytes by a number of com-
panies (Webb, 2009). In this context, the focus of quality
assurance shifts from patient safety concerns to the devel-
opment and adoption of measures that ensure these cells
reliably mimic cardiac myocytes found in vivo.
In order to develop quality assurance standards for assess-
ing stem cell-derived myocyte differentiation, it is neces-282 Stem Cell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authsary to first establish the set of characteristics that reliably
define cardiac myocyte identity. We reasoned that the
most effective way to delineate these standards was to
comprehensively evaluate the aspects of form and function
that give rise to the contractile properties of cardiac myo-
cytes in the healthy, postnatal heart (Sheehy et al., 2012).
No standardized approach currently exists for evaluating
cardiac differentiation. Basic characterization involves the
use of one or more assays with stringencies ranging from
the observation of spontaneous beating activity to electro-
physiological recordings, and one of the most commonly
used approaches is gene-expression profiling (Mummery
et al., 2012). In addition tomeasuring the expression of car-
diac biomarker genes (Bruneau, 2002; Ng et al., 2010), we
also examined the organizational characteristics of the
contractile myofibrils (Feinberg et al., 2012), the electrical
activity that regulates myofibril contraction (Kle´ber and
Rudy, 2004), and contractile force output directly (Alford
et al., 2010). Since human ventricular myocytes are not
readily available, we utilized commercially available mu-
rine embryonic stem cell (mESC)- and induced pluripotent
stem cell (miPSC)-derived myocytes and compared them
against ventricularmyocytes freshly isolated fromneonatal
mice (neonate). Although humans and mice exhibit differ-
ences in cardiac physiology, our goal was to determine the
utility of comparing industrially manufactured stem cell-
derived myocytes and isolated cardiac myocytes that
possess the desired phenotype, using a multifactorial com-
parison of high-level myocardial tissue architectural and
functional characteristics.ors
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Gene-Expression Profiling of mESC, miPSC, and
Neonate Engineered Tissues
We previously reported the influence of tissue architecture
on the contractile performance of engineered myocardium
in vitro, so we began our characterization of commercially
available mESC and miPSC myocytes by evaluating their
response to geometric cues encoded in the extracellular
matrix (ECM) (Feinberg et al., 2012) and measuring the
expression of genes that are commonly used to delineate
the cardiac myocyte lineage (Maltsev et al., 1994; Sartiani
et al., 2007). Culturing the mESC (Figure 1Ai) and miPSC
(Figure 1Aii) myocytes on a substrate coated uniformly
with fibronectin (FN) gave rise to monolayers with an
isotropic cellular arrangement similar to the arrangement
observed when neonate ventricular myocytes (Figure 1Aiii)
were cultured in a similar manner. Moreover, mESC (Fig-
ure S1Ai available online), miPSC (Figure S1Aii), and
neonate (Figure S1Aiii) myocytes all assumed a pleomor-
phic morphology when cultured sparsely on isotropic FN
(FigureS1B), even though theneonate cardiacmyocytesdis-
played a smaller surface area than the mESC and miPSC
myocytes (Figure S1C). A comparison of the expression pro-
files for isotropic mESC- (Figure 1Bi) and miPSC- (Fig-
ure 1Bii) derived tissues versus the neonate tissues revealed
a number of significant differences associated with ion
channel subunits and components of the sarcomere. In
particular, the mESC tissues exhibited significantly higher
expression of the L-type Ca2+ channel subunit Cacna1d
(4.9-fold, p < 0.05), as well as the T-type subunits Cacna1g
(9.0-fold, p < 0.05) and Cacna1h (42.2-fold, p < 0.05) versus
neonate tissues. Isotropic mESC tissues also showed signifi-
cantly lower expression of Irx4 (9.1-fold, p < 0.001),Myl2
(3.2-fold, p < 0.05), andMyl3 (3.8-fold, p < 0.01), which
are commonly associated with the ventricular myocyte
phenotype (Nget al., 2010), and significantlyhigher expres-
sion of the atrial marker genes Myl4 (40.2-fold, p < 0.001)
and Myl7 (24.5-fold, p < 0.01) than the neonate isotropic
tissues. In contrast, the miPSC isotropic tissues showed
significant differences in expression for Cacna1d (5.7-fold,
p < 0.05), Cacna1h (27.9-fold, p < 0.001), Myl4 (14.1-fold,
p < 0.05), and Myl7 (11.1, p < 0.05) versus the neonate
isotropic tissues. These observations suggest that compared
with themESC-derivedmyocytes, the miPSC-derivedmyo-
cytes exhibited an expression profile that more closely
resembled the profile of the neonate ventricular myocytes.
Based on previous studies, we recognized that the gene-
expression profile of cardiac myocytes changes as a func-
tion of the tissue architecture within which they are
embedded (McCain et al., 2013). We engineered laminar,
anisotropic myocardium from mESC (Figure 1Ci), miPSC
(Figure 1Cii), and neonate cardiac myocytes by culturingStem Cthem on microcontact-printed FN, where the cells sponta-
neously formed cell-cell junctions and aligned with the
geometric cues within the matrix to form a contiguous tis-
sue of high-aspect-ratio cells (Figures S1D and S1E). After
several days of tissue culture, we measured and compared
the expression profiles of these engineered tissues. A com-
parison of the expression profiles for anisotropic neonate
and mESC tissues (Figure 1Di) revealed a number of differ-
ences associated with Ca2+ channel subunits, such as the
L-type Ca2+ channel subunit Cacna1d (37.5-fold, p <
0.0001), as well as the T-type subunits Cacna1g (20.2-fold,
p < 0.05) and Cacna1h (23.8-fold, p < 0.05). Additionally,
the mESC anisotropic tissues showed significantly lower
expression of the ventricular marker Irx4 (7.7-fold,
p < 0.05) and significantly higher expression of the atrial
markers Myl4 (254.8-fold, p < 0.01) and Myl7 (104.0-fold,
p < 0.01) versus the neonate tissues.
In contrast, the miPSC anisotropic tissues exhibited sig-
nificant differences from the neonate tissues (Figure 1Dii)
for the Ca2+ channel subunits Cacna1d (36.9-fold, p <
0.05) and Cacna1g (6.6-fold, p < 0.05), as well as the atrial
myosin light chain kinase gene Myl4 (105.5-fold, p <
0.01). Hierarchical clustering of neonate, mESC, and
miPSC gene-expression measurements revealed a distinct
separation of the expression profiles for isotropic and
anisotropic tissues, regardless of myocyte type (Figure 1E).
Moreover, the expression profiles for mESC and miPSC
myocytes in both the isotropic and anisotropic cellular
configurations clustered closer to each other than to the
neonate tissues. This suggests that the mESC and miPSC
myocytes exhibited global transcriptional profiles that
were distinct from the neonate expression pattern, despite
differences in the relative expression profiles between the
mESC and miPSC tissues.
Characterization of Myofibril Architecture and Global
Sarcomere Alignment
One of the defining features of the ventricularmyocardium
is the laminar arrangement of cardiac myocytes, which
serves to organize and orient the contractile sarcomeres
to facilitate efficient pump function (McCain and Parker,
2011). We evaluated the ability of the mESC and miPSC
engineered tissues to self-assemble myofibrils with align-
ment comparable to that of neonate ventricular myocytes
by using custom image analysis software developed in
our lab. Immunofluorescence micrographs of sarcomeric
a-actinin allowed us to visualize the orientations of the z
lines outlining the lateral edges of sarcomeres, and to quan-
titatively assess sarcomere organization in our engineered
tissues (Figure S2Bi–S2Bii). Visualization of global z-line
registration in isotropic monolayers of mESC (Figure 2Ai),
miPSC (Figure 2Aii), and neonate (Figure 2Aiii) myocytes
revealed random orientation patterns. In contrast, theell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authors 283
Figure 1. Comparison of mESC, miPSC, and Neonate Gene-Expression Profiles on Isotropic and Anisotropic ECM Substrates
(A) Culturing (i) mESC, (ii) miPSC, and (iii) neonate myocytes on substrates with a uniform coating of FN resulted in isotropic cellular
arrangement.
(B) Volcano plots showing the negative log of p values (two-tailed t test, n = 3 for all conditions) versus log fold-change values for
comparison of qPCR measurements of cardiac genes (i) between mESC and neonate isotropic monolayers, and (ii) between miPSC and
neonate isotropic monolayers reveal significant differences for a number of genes (points on the plot colored green or red represent genes
with p < 0.05).
(C) Culturing (i) mESC, (ii) miPSC, and (iii) neonate myocytes on substrates with microcontact-printed lines of FN that were 20 mm wide
and spaced 4 mm apart resulted in anisotropic cellular arrangement in all three cell types.
(D) Volcano plots showing the negative log of p values (two-tailed t test, n = 3 for all conditions) versus log fold-change values for
comparison of qPCR measurements of cardiac genes (i) between mESC and neonate anisotropic monolayers, and (ii) between miPSC and
neonate anisotropic monolayers reveal slightly fewer genes demonstrating significant differences than in the isotropic cultures (points on
the plot colored green or red represent genes with p < 0.05).
(legend continued on next page)
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neonate (Figure 2Biii) tissues demonstrated a greater degree
of uniaxial z-line registration. To quantify the differences in
global sarcomere organization between the mESC and
miPSC tissues versus the neonate tissues (Figure 2C), we
utilized a metric known as the orientational order param-
eter (OOP), which is commonly used to characterize the
alignment of liquid crystals (Kuczynski et al., 2002) and
ranges from zero (random organization) to one (perfect
alignment). It was previously shown that this metric can
be successfully adapted to measure and compare z-line
registration in engineered cardiac tissues, and that it pro-
vides insight into the contractile strength of the tissues
(Feinberg et al., 2012). The anisotropic neonate tissues ex-
hibited a significantly higher OOP value than both the
mESC and miPSC tissues, suggesting that both types of
stem cell-derived cardiac myocytes were unable to generate
myofibrils with the same degree of global sarcomere align-
ment as the neonate myocytes. Isotropic tissues had low
OOP values due to the random organization of the cardiac
myocytes. Measurement of registered z-line spacing also re-
vealed that the anisotropic mESC and miPSC tissues dis-
played significantly shorter sarcomere lengths than the
neonate tissues (Figure 2D). Moreover, quantification of
‘‘sarcomere packing density’’ (i.e., the proportion of a-acti-
nin localized to z lines indicative of the presence of fully
formed sarcomeres) showed that the anisotropic neonate
tissues exhibited significantly higher sarcomere packing
density than the mESC and miPSC tissues. Taken together,
these analyses revealed that the mESC- and miPSC-derived
myocytes responded to ECM cues in a manner similar to
that observed for the neonate myocytes, but exhibited
sarcomere organization reminiscent of immature premyo-
fibrils observed in embryonic cardiac myocytes (Dabiri
et al., 1997; Grosberg et al., 2011b; LoRusso et al., 1997).
Measurement of mESC, miPSC, and Neonate
Electrophysiological Performance
The electrical activity of cardiac myocytes regulates the
initiation of myofibril contraction and is commonly
measured as an indicator ofmyocyte identity and function-
ality (Kle´ber and Rudy, 2004;Maltsev et al., 1994;Weinberg
et al., 2010). We used planar patch-clamp recordings to
compare and contrast the action potential (AP) characteris-
tics of isolated mESC, miPSC, and neonate myocytes. We
identified two different demographics of cell types as
demonstrated by AP morphology (Maltsev et al., 1994).(E) Hierarchical clustering of mean 2-DCt values for a select panel of car
expression profiles cluster together in the center columns of the hea
form a separate cluster on the right sides of the heatmap, and the isotr
heatmap. Scale bars, 100 mm.
See also Figure S1 and Table S1.
Stem CNeonate myocytes primarily demonstrated ventricular-
like APs (Figure 3Ai), whereas mESC- and miPSC-derived
myocytes exhibited APs that were evenly distributed be-
tween ventricular-like and atrial-like morphologies (Fig-
ure 3Aii). Both the mESC- and miPSC-derived myocytes
primarily exhibited APs, as shown in Figure 3Aii, whereas
the neonate ventricular myocytes demonstrated APs, as
illustrated in Figure 3Ai. Analysis of AP characteristics,
such asmaximumvoltage (Vmax), AP duration at 50% repo-
larization (APD50), and AP duration at 90% repolarization
(APD90), revealed that the mESC and miPSC myocytes
exhibited roughly equal incidences of atrial-like and ven-
tricular-like APs, whereas the neonate cardiacmyocytes dis-
played ventricular-like AP characteristics (Figure 3B). In
addition to AP characterization, we also measured the elec-
trical conduction properties of the anisotropic mESC (Fig-
ure 3Ci), miPSC (Figure 3Cii), and neonate (Figure 3Ciii)
tissues using optical mapping and the voltage-sensitive
fluorescent dye RH-237 (Bursac et al., 2002; Thomas
et al., 2000; Weinberg et al., 2010) to evaluate the ability
of the stem cell-derived myocytes to form the electrome-
chanical syncytium that typifies the myocardium (Kle´ber
and Rudy, 2004). We did not observe any significant differ-
ences in the longitudinal (LCV) or transverse (TCV)
conduction velocities between the mESC, miPSC, and
neonate tissues (Figure 3D). However, we did observe sub-
stantial differences in the cellular dimensions (l 3 w) of
mESC (72.04 mm 3 12.07 mm) and miPSC (82.30 mm 3
11.25 mm) versus neonate (44.93 mm 3 11.35 mm) cardiac
myocytes that may influence the magnitude of the LCV
and TCV in engineered tissues comprised of these
cells, making them appear faster than they actually are.
AP duration measurements revealed no significant differ-
ences at 50% repolarization (APD50), but a significant
(p < 0.05) difference was observed at 90% repolarization
(APD90) between the neonate and mESC anisotropic tis-
sues (Figure 3E).
Ca2+ plays a crucial role in coupling myocyte excitation
and contractile activity (Bers, 2002). We measured Ca2+
transient activity in engineered anisotropic tissues, as
well as the Ca2+ current profiles of isolated mESC, miPSC,
and neonate myocytes. Ca2+ transients measured in aniso-
tropic tissues revealed a significantly (p < 0.05) shorter 50%
decay time in the miPSC, but not the mESC, tissues as
compared with the neonate tissues, and significantly
(p < 0.05) shorter 90% decay time in both the mESC and
miPSC tissues versus the neonate tissues (Figure 3F). Planardiac genes reveals that the isotropic and anisotropic neonate tissue
tmap, whereas the anisotropic mESC and miPSC expression profiles
opic mESC and miPSC profiles cluster together on the left side of the
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Figure 2. Comparison of Myofibril Architecture in mESC, miPSC, and Neonate Engineered Tissues
(A and B) Immunofluorescence visualization of sarcomeric a-actinin in (A) isotropic monolayers of (i) mESC, (ii) miPSC, and (iii) neonate
myocytes, and (B) anisotropic monolayers of (i) mESC, (ii) miPSC, and (iii) neonate myocytes reveals the pattern of sarcomere organization
adopted by each cell type in response to geometric cues encoded in the ECM. Immature premyofibrils (red arrows) were observed
exclusively in mESC and miPSC engineered tissues. Quantitative evaluation of sarcomeric a-actinin immunofluorescence micrographs
allowed statistical comparison of sarcomere organization and architecture.
(C) The OOP was used as a metric of global sarcomere alignment within the engineered tissues and showed that anisotropic neonate tissues
exhibited significantly greater overall sarcomere alignment than the mESC and miPSC anisotropic tissues. No significant differences in
global sarcomere alignment were observed among the isotropic mESC, miPSC, and neonate tissues.
(D) Comparison of z-line spacing revealed that the neonate anisotropic tissues exhibited significantly greater sarcomere length than both
the mESC and miPSC anisotropic tissues.
(E) From the measurements of sarcomere length, the sarcomere packing density was calculated for anisotropic tissues of each cell type. All
three cell types exhibited significantly different sarcomere packing densities. The statistical tests used were ANOVA (*p < 0.05) and ANOVA
on ranks (yp < 0.05). Data are presented as mean ± SEM. Scale bars, 10 mm.
See also Figure S2.
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T-type (TCC; Figure 3Gii) Ca2+ current profiles revealed
significantly (p < 0.05) higher total (TOT) and TCC
maximum Ca2+ current densities in the neonate myocytes286 Stem Cell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authversus themESC-derived, but not themiPSC-derived, myo-
cytes (Figure 3H). Taken together, these data suggest that
the mESC and miPSC myocytes possessed electrophysio-
logical properties similar to those of neonate cardiacors
Stem Cell Reports
Stem Cell Quality Metricsmyocytes, aside from differences in funny current and
voltage-gated Ca2+ channel subunit expression (illustrated
in Figure 1).
Measurement of mESC, miPSC, and Neonate
Engineered Tissue Contractile Performance
With the muscular thin film (MTF) contractility assay, it is
now possible to assess the diastolic (Figure 4Ai) and systolic
(Figure 4Aii) functions of engineered myocardium directly
(Alford et al., 2010; Feinberg et al., 2007; Grosberg et al.,
2011a). Using the ‘‘heart-on-a-chip’’ MTF assay (Grosberg
et al., 2011a), we measured the stress generation profiles
of anisotropic mESC, miPSC, and neonate tissues (Fig-
ure 4B), and compared their contractile performance. The
anisotropic neonate tissues generated significantly (p <
0.05) higher diastolic, peak systolic, and twitch stress
than both the mESC and miPSC tissues (Figure 4C), with
the observed values for the neonate tissues being within
the range measured for isolated murine papillary muscle
strips (Gao et al., 1998; Stuyvers et al., 2002). The results
of the contractilitymeasurements clearly showa functional
deficit in the mESC- and miPSC-derived myocytes that was
not apparent in the electrophysiological measurements.
We used the combined output of our electrophysiological,
calcium transient, and contractile force experimental mea-
surements to create graphical representations of the excita-
tion-contractioncouplingprofiles of themESC(Figure4Di),
miPSC (Figure 4Dii), and neonate (Figure 4Diii) engineered
tissues that clearly illustrate the similarities and differences
in the excitation-contraction coupling among the cell
types. These data show that the miPSC-derived myocytes
are qualitatively more similar to the neonate myocytes
than are the mESC-derived myocytes.
Integration of Experimental Measurements to
Evaluate the Stem Cell-Derived Myocyte Cardiac
Phenotype
To determine how closely the mESC- and miPSC-derived
myocytes matched the phenotype of the neonate ventricu-
lar myocytes, we computationally integrated the set of
gene-expression, morphology, electrophysiology, and con-
tractility experimental measurements collected from each
cell population, and calculated the difference between
the unknown and target cell populations. For this purpose,
we evaluated measures of effect size, such as the z factor
and strictly standardized mean difference (SSMD), that
have previously been used to quantify biological popula-
tion differences in high-throughput screening applications
(Birmingham et al., 2009). We chose to use the SSMD
instead of the z factor in this case study because the
SSMD is more robust to outliers, is not dependent on sam-
ple size, and can be used to evaluate non-normal data
(Zhang, 2007). For each type of experimental measure-Stem Cment, we normalized the mean (mnorm) values to the inter-
val [0,1] by identifying themaximum (mmax) andminimum
(mmin) mean values observed for that measurement from all
three cardiac myocyte sources, and calculating as follows:
mnorm =
m mmax
umax  mmin
(Equation 1)
Using these normalized values, we calculated the SSMD
(b) and quantified the differences between each unknown
population (i.e., mESC and miPSC) and the neonate target
population as follows:
b=
mtarget  munknownﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2target + s
2
unknown
q (Equation 2)
where m represents the mean and s represents the SD. We
used the results to evaluate the magnitude of difference,
taking into account the variance in the measurements,
between the stem cell-derived myocytes and the neonate
cardiac myocytes (Figure 5). This allowed us to identify
the parameters that showed the greatest degree of similarity
to and difference from the target neonate ventricular myo-
cyte tissues. We then used the b values from each experi-
mental measurement for the mESC and miPSC tissues,
and calculated the mean squared error (MSE) versus the
neonate tissues as follows:
MSE=
1
n
Xn
i=1
b2i (Equation 3)
where n is the total number of experimental measurement
b values included in the calculation. We then used these
results to evaluate the differences observed for each mea-
surement category (i.e., the b values for gene expression,
morphology, electrical activity, contractility used to calcu-
late category-specific MSE values), as well as to define a
single MSE value calculated from all of the experimental
measurements from all categories combined that repre-
sents the total difference between the stem cell-derived
and neonate cardiac myocytes based on the measurements
performed (Table 1). A lower MSE value indicates a better
match to the neonate target phenotype, with anMSE value
of zero indicating a perfect match.
We found that the miPSC tissues exhibited lower MSE
values than the mESC tissues in every measurement cate-
gory except morphology. In addition, the overall MSE
values calculated from all of the experimental measure-
ments combined revealed a lower MSE for the miPSC engi-
neered tissues than for those comprised of mESC-derived
myocytes. This suggests that the miPSC-derived myocytes
exhibited a global phenotype that was slightly closer to
the neonate cardiac myocytes than the mESC-derived
myocytes, although both the mESC- and miPSC-derivedell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authors 287
Figure 3. Comparison of Electrical Activity in mESC, miPSC, and Neonate Engineered Tissues
(A) Patch-clamp recordings from isolated mESC, miPSC, and neonate myocytes exhibited APs with both (i) ventricular-like and (ii) atrial-
like profiles.
(B) Characterization of the AP traces revealed no significant differences between the three cell types, but the mESC and miPSC myocytes
exhibited an equal proportion of ventricular-like (mESC-v, miPSC-v) and atrial-like (mESC-a, miPSC-a) AP traces, whereas the neonates
exhibited primarily ventricular-like (neonate-v) AP profiles.
(C) The electrophysiological characteristics of anisotropic (i) mESC, (ii) miPSC, and (iii) neonate tissues were assessed using optical
mapping and the photovoltaic dye RH237.
(D) Comparison of conduction properties between the mESC, miPSC, and neonate tissues revealed no significant differences in either
LCV or TCV.
(E) Evaluation of optical AP duration in anisotropic tissues revealed no significant differences in APD50, but a significant difference in
APD90 between the mESC and neonate tissues was observed.
(legend continued on next page)
288 Stem Cell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authors
Stem Cell Reports
Stem Cell Quality Metrics
Figure 4. Comparison of Contractile Per-
formance in mESC, miPSC, and Neonate
Engineered Tissues
(A) The contractile performance of aniso-
tropic mESC, miPSC, and neonate tissues
was assessed using the MTF assay, and the
radius of curvature of the MTFs at (i) dias-
tole and (ii) peak systole were used to
calculate contractile stress.
(B) The radius of curvature of the MTFs was
used to calculate and compare the temporal
contractile strength profiles of anisotropic
mESC (green), miPSC (red), and neonate
(blue) tissues.
(C) Comparison of MTF contractile output
revealed that neonate anisotropic tissues
generated significantly greater diastolic,
peak systolic, and twitch stress than both
the mESC and miPSC tissues.
(D) Graphical representation of AP mor-
phology (black solid line), Ca2+ transient
morphology (blue dotted line), and con-
tractility profile (red dotted line) during a
typical excitation-contraction cycle of the
mESC, miPSC, and neonate engineered
anisotropic tissues. The statistical test used
was ANOVA (*p < 0.05). Data are presented
as mean ± SEM.
See also Movies S1, S2, and S3.
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neonate cardiac myocytes for a number of characteristics.DISCUSSION
The goal of this study was to define a quality-control stan-
dard rubric for assessing stem cell-derived cardiac myo-
cytes. We chose a set of experimental measurements that
provide insight into not only the expression profile of the(F) Comparison of Ca2+ transients measured in anisotropic tissues reve
lower than that of both the mESC and neonate tissues, but the 90% de
than that of the neonate tissues.
(G) Patch-clamp recordings were collected on isolated mESC, miPSC,
elicited at various holding potentials.
(H) Patch-clamp recordings of maximum Ca2+ current density in iso
difference in TOT between the neonate and mESC myocytes. No signifi
in TCC was observed between the neonate and mESC myocytes. The s
mean ± SEM. Scale bars, 20 mm.
See also Figure S3.
Stem Ccells but also morphological and functional characteristics
that are intimately tied to the contractile function of car-
diac tissues (Bursac et al., 2002; Feinberg et al., 2012; Kle´ber
and Rudy, 2004). We utilized ventricular myocytes isolated
from postnatal mouse hearts to serve as our reference stan-
dard for defining the target phenotype. However, an
inherent limitation to using these cells is the presence of
noncardiomyocytes, such as fibroblasts, endothelial cells,
and smooth muscle cells, that may confound the inter-
pretation of some experimental measurements, such asaled that the 50% decay time of the miPSC tissues was significantly
cay time of both the mESC and miPSC tissues was significantly lower
and neonate myocytes to measure and compare (i) LCC and (ii) TCC
lated mESC, miPSC, and neonate myocytes revealed a significant
cant differences in LCC were observed, but a significant difference
tatistical test used was ANOVA (*p < 0.05). Data are presented as
ell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authors 289
Table 1. MSE Values Calculated for Each Group of Measurements
in the Comparison of mESC- and miPSC-Derived Myocytes with
Neonate Ventricular Myocytes
Measurement Category MSEmES MSEmiPS
Gene expression 5.69 4.25
Morphology 1.30 1.48
Electrophysiology 1.16 0.57
Contractility 6.32 2.95
All measurements 4.95 3.60
The SSMD (b) values computed for each experimental measurement were
used to calculate MSE values for each major measurement category (see
Table S2), as well as all of the measurements combined, in comparisons of
the mESC (MSEmES), and miPSC (MSEmiPS) engineered tissues with the
neonate engineered tissues.
Figure 5. Integrated Visual Comparison of mESC, miPSC, and
Neonate Experimental Measurements
SSMD (b) values were computed for mESC- and miPSC-derived
myocytes relative to the neonate cardiac myocytes from the mean
and sample SDs collected for each experimental measurement.
These b values were organized by measurement type (i.e., gene
expression, myocyte architecture, electrophysiology, and con-
tractility) and plotted to allow comparison. Negative b values
indicate measurements with higher relative magnitude in the
neonate cardiac myocytes, whereas positive b values indicate
measurements that were higher in the mES/miPSC myocytes rela-
tive to the neonate cardiac myocytes.
See also Table S2.
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mESC- and miPSC-derived cardiac myocytes used in this
study were produced using a differentiation protocol that
gives rise to a heterogeneous population of atrial, ventricu-
lar, and pacemaker-like cells, which may also make inter-
pretation of certain measurements challenging. However,
the proposed quality-assessment strategy is not dependent
on any particular set of measurements and allows re-
searchers the flexibility to choose the set of experimental
measurements that best suits their needs.
Using the experimental measurements described above
and isolated neonatal ventricularmyocytes as our reference
phenotype, we developed a ‘‘quality index’’ that utilizes the290 Stem Cell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authmagnitude and variance of these measurements to provide
a numeric score indicating how closely the stem cell-
derivedmyocytes match the characteristics of the neonatal
cardiac myocytes. The combination of gene-expression,
morphological, electrophysiological, and contractility
measurements employed allowed us to pinpoint specific
differences in the structural and functional properties of
themESC andmiPSC engineered tissues versus the neonate
tissues that have important implications for their utility in
in vitro assays. Additional studies of the relationships be-
tween these measurements and the response of engineered
cardiac tissues to compounds that have known effects on
heart function may provide valuable insight into the com-
bination ofmeasurements that canmost reliably determine
the ability of stem cell-derived cardiac myocytes to adopt
the desired phenotype.With a carefully chosen set of exper-
imental parameters, this quality-assessment rubric may
provide a reliablemeans to evaluate strategies for improving
the differentiation of cardiac myocytes from stem cells and
drive themtoward amorematurephenotype (Cassino et al.,
2012). Further, this quality index will not only allow re-
searchers to identify the commercial stem cell-derived
myocyteproduct lines that aremost suitable for their needs,
it may also serve the stem cell industry as a quality-assur-
ance system for ensuring that batches released to customers
faithfully recapitulate the desired phenotype.EXPERIMENTAL PROCEDURES
Stem Cell-Derived Myocyte Culture
Cor.At mESC-derived myocytes (lot# CS25CL_V_SN_1M, produc-
tion date: 2010-02-16) and iPSC-derived myocytes (lot# CS02CL-i,
production date: 2010-11-15; CS07CL-i, production date: 2011-05-
09) were cultured according to instructions and with culture
reagents supplied by the manufacturer (Axiogenesis). Briefly,
cells were cultured in T25 flasks precoated with 0.01 mg/ml FNors
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Stem Cell Quality Metrics(BD Biosciences) in puromycin-containing culture media at 37C
and 5% CO2 for 72 hr to eliminate undifferentiated stem cells
from the culture. After 72 hr, cells were dissociated with 0.25%
trypsin and seeded onto microcontact-printed substrates at
densities of 100,000/cm2. Cells were cultured for 2 days on micro-
contact-printed substrates to allow formation of a functional
syncytium while preserving the proportion of myocytes that
exhibited ventricular characteristics prior to experimentation.
Neonatal Mouse Ventricular Myocyte Culture
Neonatalmouse ventricularmyocyteswere isolated from2-day-old
neonatal Balb/c mice using procedures approved by the Harvard
University Animal Care and Use Committee. Briefly, excised ven-
tricular tissue was incubated in a 0.1% (w/v) trypsin (USB) solution
cooled to 4C for approximately 12 hr with agitation. Trypsinized
ventricular tissue was dissociated into cellular constituents via
serial exposure to a 0.1% (w/v) solution of collagenase type II (Wor-
thington Biochemical) at 37C for 2 min. Isolated myocytes were
maintained in a culture medium consisting of Medium 199 (Invi-
trogen) supplementedwith 10% (v/v) heat-inactivated fetal bovine
serum (FBS), 10 mM HEPES, 20 mM glucose, 2 mM L-glutamine,
1.5 mM vitamin B-12, and 50 U/ml penicillin, and seeded at a den-
sity of 200,000 cells/cm2. From the second day of culture onward,
the FBS concentration was reduced to 2% (v/v) and the medium
was exchanged every 48 hr. Myocytes were cultured for 4 days on
microcontact-printed substrates prior to experimentation.
Fabrication of Microcontact-Printed Substrates
Silicone stamps designed for microcontact printing were prepared
as previously described. Photolithographicmasks were designed in
AutoCAD (Autodesk), and consisted of 20 mmwide lines separated
by 4 mm gaps to impose a laminar organization on the myocytes.
Polydimethylsiloxane (PDMS, Sylgard 184; Dow Corning) was
used to fabricate stamps with the specified pattern. Stamps were
incubated with 50 mg/ml FN (BD Biosciences) for 1 hr. Glass cover-
slips were spin-coated with PDMS and treated in a UV-ozone
cleaner (Jelight) immediately prior to stamping with FN. After
the FN pattern was transferred to the surface of the PDMS-coated
coverslips, they were incubated in 1% (w/v) Pluronic F-127
(BASF) to block cell adhesion to unstamped regions.
Heart-on-a-Chip Substrate Fabrication
Engineered cardiac tissue contractile performance was measured
using a custom MTF based platform (Alford et al., 2010; Feinberg
et al., 2007; Grosberg et al., 2011a). Briefly, the heart-on-a-chip
substrates consisted of glass coverslips selectively coated with a
thermosensitive sacrificial polymer, poly(N-isopropylacrylamide)
(PiPAAm; Polysciences), and with a second layer of PDMS. The
thickness of the PDMS layer was found to be in the range of 10–
18 mm for all ‘‘heart chips’’ used in this study (Dektak 6M; Veeco
Instruments).
Heart-on-a-Chip Contractility Experiments
During contractility experiments, samples were submerged in
Tyrode’s solution (mM, 5.0 HEPES, 5.0 glucose, 1.8 CaCl2, 1.0
MgCl2, 5.4 KCl, 135.0 NaCl, and 0.33 NaH2PO4, pH 7.4). All re-
agents were purchased from Sigma-Aldrich. Rectangular filmsStem Cwere cut with a razor blade, and the bath temperature was
decreased below the PiPAAm transition temperature, making
possible for theMTF to bend away from the glass. Video recordings
of the deformation of each film were processed to obtain the time
course (Alford et al., 2010) of the tissue-generated stresses. The
peak systolic and diastolic stresses were calculated as the average
of the maxima and minima of the stress profile during 10 cycles
at a pacing of 3 Hz, and twitch stress was defined as the difference
between peak systolic and diastolic stresses.
Immunohistochemical Labeling
Sampleswere fixed in 4% (v/v) paraformaldehydewith 0.05% (v/v)
Triton X-100 in PBS at room temperature for 10 min. Cells were
incubated in a solution containing 1:200 dilutions of monoclonal
anti-sarcomeric a-actinin antibody (A7811, clone EA-53; Sigma-
Aldrich), polyclonal anti-FN antibody (F3648; Sigma-Aldrich),
DAPI (Invitrogen), and Alexa Fluor 633-conjugated phalloidin
(Invitrogen) for 1 hr at room temperature. Samples were then incu-
bated in 1:200 dilutions of Alexa Fluor 488-conjugated goat anti-
mouse IgG and Alexa Fluor 546-conjugated goat anti-rabbit IgG
secondary antibodies (Invitrogen) for 1 hr at room temperature.
Labeled samples were imaged with a Zeiss LSM confocal micro-
scope (Carl Zeiss Microscopy).
Quantitative Evaluation of Sarcomere Structure
Confocal Z stacks of sarcomerica-actininfluorescencemicrographs
were deconvolved with Mediacy Autoquant (MediaCybernetics).
Analysis of sarcomeric structural characteristics was conducted
using custom-designed ImageJ (Abramoff et al., 2004) andMATLAB
(The MathWorks) software (Figure S2A). The orientations of sarco-
meric a-actinin positive pixels were determined using an adapted
structure-tensormethod (Rezakhaniha et al., 2012) and theorienta-
tional order parameter (OOP), ameasure of the global alignment of
the sarcomeres, was calculated from the observed orientation
values. The orientations observed in the micrographs were color-
coded using the HSV digital image representation (Figure S2Bi)
where the Hue channel was used for orientation, the Saturation
channel for pixel coherency (i.e., a measure of local contrast), and
the Value channel for the preprocessed image. The normalized
occurrence of orientations that demonstrated a coherency higher
than a given threshold could then be displayed in a histogram (Fig-
ure S2Bii). The sarcomere length and the overall regularity of the
z lines were determined by processing the images with a 2D fast
Fourier transform algorithm. The power spectrum (Figure S2Ci)
was then radially integrated andnormalized by the total area under
the 1D curve. The sarcomere packing density was defined as the
area under the periodic component (shaded red in Figure S2Cii).
Planar Patch-Clamp Electrophysiological Recordings
Planar patch-clamp experiments were conducted as previously
described (Weinberg et al., 2010). Briefly, cells were cultured on
FN (BD Biosciences) coated T25 flasks for 5 days, isolated using
0.25% trypsin (Invitrogen), resuspended in extracellular buffer so-
lution (EBS [mM]: 140 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 5 D-glucose
monohydrate, 10 HEPES, pH 7.4) to a final concentration of 1,000
cells/ml, and allowed to equilibrate for 5min in EBS. The electronics
were calibrated in the presence of EBS and intracellular bufferell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authors 291
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7.2) prior to flowing cells into the chamber. Then5ml of the cell sus-
pension was introduced into the chip and the negative pressure
was automatically adjusted to produce a final seal resistance greater
than 1 GOhm. During current-clamp experiments, cells were sub-
jected to ten trains of ten current pulses at 3 Hz; the current ampli-
tudewas set to 1.5 times the threshold for AP generation.When the
signal reached steady state, ten APs were averaged, yielding a repre-
sentative trace for the calculationof APduration indicators.During
voltage-clamp experiments, cells were kept in buffers containing
tetrodotoxin (10 mM), nifedipine (10 mM), 4-AP (1mM), and tetrae-
thylammonium (20 mM) purchased from Sigma-Aldrich. The
membranepotentialwas subjected to twovoltage-clampprotocols:
First, the membrane potential was held to a value of 90 V for
250 ms and then stepped from 70 to +40 mV in 10 mV steps for
250 ms, thus eliciting the total Ca2+ current (TOT). Second, from
the same holding potential, cells were stepped from 40
to +40 mV, a range in which mostly the LCC is active. The TCC
was then calculated as the difference between the TOT and LCC.
Optical Mapping of Electrophysiological Properties
Samples were incubated in 4 mMRH237 (Invitrogen) for 5 min and
washed three times with Tyrode’s solution prior to recording. The
temperature of the bath solutionwasmaintained at approximately
35C using a digital temperature controller (TC-344B; Warner In-
struments) for the duration of the experiment. Then 10 mM Bleb-
bistatin (EMD Millipore) was added to minimize motion artifacts
during recording of electrical activity (Fedorov et al., 2007; Herron
et al., 2012). Samples were paced at 3 Hz with a 10 ms biphasic
pulse at 10–15 V delivered using an SD-9 stimulator (Grass Tech-
nologies) and a bipolar, platinum point electrode placed approxi-
mately 300–500 mm above the sample and 1–2 mm from the
top-right corner of the field of view (FOV). Imaging was performed
using a Zeiss Axiovert 200 epifluorescence microscope (Carl Zeiss
Microscopy) equipped with an X-cite Exacte mercury arc lamp
(Lumen Dynamics). Illumination light was passed through a
40X/1.3 NA objective (EC Plan-NEOFLUAR; Zeiss) and a band-
pass excitation filter (530–585 nm). Emission light was filtered at
615 nm with a long-pass filter and focused onto the 100 3 100
pixel chip of a high-speed MiCAM Ultima CMOS camera (Scime-
dia). Images were acquired at 1,000 fps from a 250 3 250 mm
FOV. Postprocessing of the raw data included reduction of drift
induced by photobleaching by subtracting a linear fit of the base-
line, applying a 33 3 pixel spatial filter to improve the signal/noise
ratio, and excluding saturated pixels. Activation time was calcu-
lated as the average maximum upstroke slope of multiple pulses
over a 2–4 s recording window. LCVs and TCVs were calculated
through a linear fit of the activation times along the horizontal
and vertical axes of each FOV, respectively. Optical AP traces
were calculated as the average of multiple pulses while adjusting
the offset of each pixel caused by different activation times.
Ratiometric Measurement of Cardiac Myocyte Ca2+
Transients
Cardiac tissues were incubated in a 5 mM solution of acetoxy-
methyl (AM) Fura Red (F-3021; Invitrogen) reconstituted in
Pluronic F-127 (P-3000MP; Invitrogen) for 20 min. After dye292 Stem Cell Reports j Vol. 2 j 282–294 j March 11, 2014 j ª2014 The Authloading, cells were incubated in Tyrode’s solution for 5 min, rinsed
three times, and imaged on a Zeiss LSM LIVE (Carl Zeiss Micro-
scopy) confocalmicroscope at 403magnificationwith an environ-
mental chamber to ensure a constant physiological temperature of
37C. Tissues were field stimulated at 3 Hz during recordings. Dual-
excitation ratiometric recordings were performed by rapidly
switching (through an acousto-optical tunable filter) excitation
laser lights at 405 nm and 488 nm, and collecting the correspond-
ing emissions through a high-pass filter with cutoff at 546 nm.
Recordings were constrained to 20 lines oriented perpendicular
to the main axis of the cells and ensuring minimal intersection
with nuclei to maintain an acquisition speed of 250 fps (Fig-
ure S3A). After background subtraction, two signals were obtained
(Figure S3B): one (blue line) that increased with the Ca2+ elevation
corresponding to excitation at 405 nm, and one (green line) that
showed an opposite trend and corresponded to the 488 nm excita-
tion wavelength. The ratiometric representation of the Ca2+ tran-
sient was taken as the ratio of the 405 nm and 488 nm signals
(black trace in Figure S3C). Four consecutive transients at steady
state were further averaged to create a representative single tran-
sient (Figure S3D).Quantitative RT-PCR Gene-Expression Measurements
Total RNA was collected in triplicate from both isotropic and
micropatterned anisotropic samples using the Strategene Abso-
lutely RNA Miniprep kit (Agilent Technologies) according to the
manufacturer’s instructions. Genomic DNA contamination was
eliminated by incubating the RNA lysates in DNase I digestion
buffer at 37C for 15 min during the RNA purification procedure.
The quantity and purity of the RNA lysates were assessed using a
Nanodrop spectrophotometer (Thermo Scientific). Purified total
RNA lysates with OD 260/280 ratios greater than 1.7 were used
for quantitative RT-PCR (qRT-PCR) measurements. cDNA strands
were synthesized for genes of interest using an RT2 first-strand syn-
thesis kit (QIAGEN) and custom preamplification primer sets
(QIAGEN). For each first-strand synthesis reaction, 500 ng of total
RNA from each lysate was used. Expression levels for specific genes
of interest (Table S1) were measured using custom RT2 Profiler RT-
PCR arrays (QIAGEN) and the Bio-Rad CFX96 RT-PCR detection
system. Statistical analysis of qRT-PCR threshold cycle data was
carried out with the web-based RT2 Profiler PCR Array Data anal-
ysis Suite version 3.5 (QIAGEN) according to published guidelines
(Schmittgen and Livak, 2008).
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